Enhanced survival of patients with colon and rectal cancer is based upon wide anatomic resection.

Por Enker, W E, Laffer, U T, Block, G E
Publicado em 1979

SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer

Por Boulay, J-L, Mild, G, Lowy, A, Reuter, J, Lagrange, M, Terracciano, L, Laffer, U, Herrmann, R, Rochlitz, C
Publicado em 2002

SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer

Por Boulay, J-L, Mild, G, Lowy, A, Reuter, J, Lagrange, M, Terracciano, L, Laffer, U, Herrmann, R, Rochlitz, C
Publicado em 2003

Infrequent mutation of the tumour-suppressor gene Smad4 in early-stage colorectal cancer

Por Mamot, C, Mild, G, Reuter, J, Laffer, U, Metzger, U, Terracciano, L, Boulay, J-L, Herrmann, R, Rochlitz, C
Publicado em 2003